Coloplast stock holds at DKK 493.60 as results approach

Coloplast A/S stock (ISIN DK0060448595) closed at DKK 493.60 on Nasdaq Copenhagen on September 21, 2026. The quotation was DKK 156.40 below the 52-week high of DKK 650.00 and DKK 46.60 above the 52-week low of DKK 447.00, giving investors a defined range for the current valuation.

Stock stays below yearly high

The September 21, 2026 close places Coloplast 24.06 percent below its 52-week high and 10.43 percent above its 52-week low. The reference range is more informative than a single-session move because it shows that the stock is trading closer to the lower end of its annual band than to the upper boundary.

For investors, the next decisive comparison is between the market level and the company's most recent reported operating figures. Revenue, operating profit, margin and guidance need to be assessed against the precise reporting period rather than against the publication date of a market update.

Results provide the next checkpoint

Coloplast's upcoming results are the central operating checkpoint for the share price. A new revenue figure, operating result and margin would allow the market to compare current execution with the prior reporting period and to judge whether the DKK 493.60 quotation reflects improving or weakening fundamentals.

The price structure supplies a concrete counter-factor: the stock remains DKK 156.40 below the annual high while standing DKK 46.60 above the annual low, so a move toward either boundary would materially change the current range assessment.

Nasdaq Copenhagen close at DKK 493.60

Coloplast stock closed at DKK 493.60 on Nasdaq Copenhagen as of September 21, 2026. The same dated market context records a 52-week range from DKK 447.00 to DKK 650.00.

More news and analyses on Coloplast stock